SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?


To: Doug Shapiro who wrote (412)10/1/1998 10:34:00 AM
From: Gerald Underwood  Read Replies (1) | Respond to of 857
 
Au Contraire,

This type of immediate and coherent action is needed to assure shareholders that their company and capitol assets are being defended against this type of thing. No one wants to feel that they are subject to a downdraft in their holdings due to anything an analyst wants to say about them, founded or unfounded. Analyst's have to be held responsible for direct accusations and unfounded statements that may drastically affect the stock price and the stockholders need to be aware that this action is being taken without delay.

As for scrutiny, any company is aware that they will be subjected to more scrutiny in a lawsuit. This indicates to me that they are willing to and believe that additional exposure will vindicate them.

IMO, in view of the allegations made against HEB, such reaction is definitely called for.



To: Doug Shapiro who wrote (412)10/1/1998 12:31:00 PM
From: RealMuLan  Read Replies (1) | Respond to of 857
 
FWIW, I do like the company's reaction to Asensio's lie. So many small companies have been ruined by him. And it is high time for someone to fight back. The only pity is that even if the company wins the law suit, it is highly unlikely to recover much money from this scum bag, because I heard that Asensio put most of his money under his mother's name. Maybe it is the time for him to sit behind the bar for a while.

Looks like smart shorts already started to cover, only some bone-head small investors continue to short. Interesting.



To: Doug Shapiro who wrote (412)10/5/1998 10:13:00 PM
From: Mad2  Read Replies (1) | Respond to of 857
 
Doug, your correct in that HEB stands little chance in benifiting from their lawsuit with Asensio. This lawsuit however will likely have the effect of bouncing their stock and fostering the belief that that they have a marketable drug. It's entertaining to follow.